Breaking News on Contract Research, Manufacturing & Clinical Trials

Bulk drug centre planned in India

29-Sep-2004 - The port city of Visakhapatnam in India is to form a 'pharma city' to house bulk drug manufacturers, according to local news reports.

Peptisyntha increases US peptide capacity

21-Sep-2004 - Solvay subsidiary Peptisyntha is boosting its capacity to make peptides at its facilities in California, US, in anticipation of increasing numbers of drugs in this class coming through to market.

Rhodia cuts back at UK facility

20-Sep-2004 - Rhodia Pharma Solutions is reducing the workforce at its Dudley site in the UK by up to 85 jobs in a continuing shake-up of the company's custom manufacturing and intermediates business.

UK firm sells facility to contract manufacturer

08-Sep-2004 - UK biotechnology company Xenova has completed the disposal of its manufacturing facility in Edmonton, Canada, to local firm QSV Biologics for C$7.0 million (€4.5m).

BASF site becomes new API player

07-Sep-2004 - BASF says it has entered into a multi-million pound management buyout deal for its specialist pharmaceutical ingredients manufacturing business at Cramlington in Northumberland, UK.

Unichem's US plans take shape

06-Sep-2004 - Unichem Laboratories of India, a major supplier of active pharmaceutical ingredients (APIs) and finished pharmaceuticals in the country, has entered into an alliance that could see it supplying generics into...

Rhodia facility upgrades on track

01-Sep-2004 - Rhodia Pharma Solutions' Chambers Works facility in New Jersey is now up and running. The company supplies preclinical and clinical trial materials and launch volumes of active pharmaceutical ingredients (APIs)...

Akzo Nobel takes steps to revamp ailing pharma business

31-Aug-2004 - Akzo Nobel has unveiled a plan to 'fix' its troubled pharmaceuticals businesses, hit by patent expirations, safety concerns with some core product lines and a difficult operating environment for contract...

Degussa turning a corner in 2Q?

10-Aug-2004 - Building on a stronger start to the year, Germany's third largest chemicals group reports continued growth into the second quarter with an increase in demand pushing up sales and earnings.

Dowpharma to close biopharma facility

02-Aug-2004 - Dowpharma has announced plans to close its biopharmaceutical contract manufacturing facility in Smithfield, Rhode Island.

India's SRF looking to enter intermediates business

29-Jul-2004 - Indian industrial chemicals group SRF Ltd is planning an entry into the pharmaceutical chemicals business, according to national press reports.

Lonza to use novel biocatalysis process for chiral compound

27-Jul-2004 - Switzerland's Lonza Group said yesterday that it will use a novel process developed by US-based biocatalysis company Codexis for the synthesis of a key chiral pharmaceutical compound used in one...

Lonza first half reflects manufacturing slump

22-Jul-2004 - Pressure on pharma ingredient supplier Lonza has continued into the first half of the year, with consistently low use of custom manufacturing capacity and weak demand for biomanufacturing contributing to...

LSBC gains new manufacturing deal

22-Jul-2004 - Californian company Large Scale Biology is to extract and purify a new plant-made antibody designed to control dental caries.

Siegfried chemicals under pressure, but biologics healthy

20-Jul-2004 - Swiss fine chemicals company Siegfried has been insulated from the general downturn in the chemicals industry, but has finally succumbed and been forced to lose staff and cut back production,...

Restructuring takes hold at Akzo; pharma still under pressure

19-Jul-2004 - Dutch pharmaceuticals and chemicals group Akzo Nobel has reported a small decline in sales in the first half of the year, although the cost of ongoing restructuring caused net earnings...

Lancaster Synthesis changes hands

13-Jul-2004 - Swiss chemicals group Clariant, currently in the throes of a major restructuring exercise, has sold off its UK-based Lancaster Synthesis unit to Johnson Matthey.

Chromos, Lonza in cell production pact

12-Jul-2004 - Lonza Biologics has licensed rights its proprietary CHOK1SV cell line to Canadian firm Chromos Molecular Systems for a project aimed at making improved mammalian cells for biological syntheses.

Sun to merge with bulk antibiotic company

07-Jul-2004 - Sun Pharma of India has announced plans to buy an ailing cephalosporin bulk active company, Phlox Pharma, to gain access to an internationally approved generic active pharmaceutical ingredient.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...